GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-07-22 22:05 |
GENFIT : premières décisions concernant la nouvelle orientation stratégique
|
French | 507.7 KB | ||
| 2020-07-10 22:05 |
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Comme…
|
English | 436.4 KB | ||
| 2020-07-10 22:05 |
GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Indu…
|
French | 432.8 KB | ||
| 2020-07-07 22:05 |
GENFIT: Enhances Board of Directors with Two Strategic Appointments
|
English | 177.4 KB | ||
| 2020-06-30 22:05 |
GENFIT : Résultats de l’assemblée générale ordinaire du 30 juin 2020
|
French | 186.2 KB | ||
| 2020-06-30 22:05 |
GENFIT: June 30, 2020 Annual Shareholders Meeting results
|
English | 184.5 KB | ||
| 2020-06-19 17:45 |
GENFIT annonce que son Assemblée Générale Ordinaire sur deuxième convocation au…
|
French | 195.4 KB | ||
| 2020-06-19 17:45 |
GENFIT: Annual Shareholders Meeting on second convening to be held on June 30, …
|
English | 241.4 KB | ||
| 2020-05-18 22:15 |
GENFIT: Reports First Quarter 2020 Financial Information GENFIT: Reports First …
|
English | 422.9 KB | ||
| 2020-05-07 22:15 |
GENFIT : Assemblée générale ordinaire du 11 juin 2020 – modalités de mise à dis…
|
French | 262.5 KB | ||
| 2020-05-07 22:15 |
GENFIT: Annual Shareholders Meeting of June 11, 2020 – Availability of Preparat…
|
English | 336.8 KB | ||
| 2020-02-20 23:52 |
GENFIT : levée d’aveugle des données de la Phase 3 RESOLVE-IT différée
|
French | 174.9 KB | ||
| 2020-02-20 23:52 |
Correction - GENFIT: Unblinding of Phase 3 RESOLVE-IT Data Deferred
|
English | 371.6 KB | ||
| 2020-02-20 22:05 |
GENFIT : levée d’aveugle des données de la Phase 3 RESOLVE-IT différée
|
French | 174.9 KB | ||
| 2020-02-20 22:05 |
GENFIT: Unblinding of Phase 3 RESOLVE-IT Data Deferred
|
English | 223.2 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
